Studies have shown that consuming sesame seeds helps prevent allergies.

Published Date: 06 Mar 2023

Oral desensitization using crushed sesame seeds and tahini may be a safe and effective method to desensitize pediatric patients with sesame allergy...

Read Full News

Latest News

Strange Asymptomatic Rash Affects Young Man With Obesity for 2 Years

Diagnosis implicates high triglycerides as a contributor

Ambulatory Surgery May Be an Option for Troublesome HS

A wave of recently approved therapies has improved options for the control of hidradenitis suppurativa, but surgery remains a possible option for faster clinical benefit.

People With Atopic Eczema Stick With Dupilumab Longer

Real-world data shows dupilumab had higher 1-year treatment continuation than oral or subcutaneous methotrexate and ciclosporin.

Skip the Stairs: The Elevator Approach to Psoriasis

Rheumatologists and gastroenterologists don’t save their best drugs until last; neither should dermatologists.

An Expert TheraTalk on the Next Wave in Psoriasis Treatment: From Mechanistic Pathways to Clinical Practice

An Expert TheraTalk on the Next Wave in Psoriasis Treatment: From Mechanistic Pathways to Clinical Practice

Updates in Hidradenitis Suppurativa: Underlying Pathogenic Mechanisms and Novel Targeted Treatments

Updates in Hidradenitis Suppurativa: Underlying Pathogenic Mechanisms and Novel Targeted Treatments

Todays Updates

Real-World EV Plus Pembro Success Seen in Urothelial Cancer

A retrospective study evaluates outcomes associated with first-line enfortumab vedotin plus pembrolizumab vs gemcitabine plus cisplatin in patients with metastatic urothelial carcinoma.

Germline Variants Predict Lobular Breast Cancer Recurrence

For women with invasive lobular carcinoma, pathogenic variants in breast cancer risk genes predict high odds of early recurrence.

MRI Enhancement Predicts Breast Cancer in BRCA Carriers

Higher background parenchymal enhancement on breast MRI may signal greater risk among women who carry BRCA mutations.

Polatuzumab Vedotin Boosts Survival in Relapsed DLBCL

Patients with relapsed or refractory diffuse large B-cell lymphoma, who were ineligible for autologous stem cell transplant, were randomly assigned to receive Pola-R-GemOx or R-GemOx.

Todays Updates

Real-World EV Plus Pembro Success Seen in Urothelial Cancer

A retrospective study evaluates outcomes associated with first-line enfortumab vedotin plus pembrolizumab vs gemcitabine plus cisplatin in patients with metastatic urothelial carcinoma.

Germline Variants Predict Lobular Breast Cancer Recurrence

For women with invasive lobular carcinoma, pathogenic variants in breast cancer risk genes predict high odds of early recurrence.

MRI Enhancement Predicts Breast Cancer in BRCA Carriers

Higher background parenchymal enhancement on breast MRI may signal greater risk among women who carry BRCA mutations.

Polatuzumab Vedotin Boosts Survival in Relapsed DLBCL

Patients with relapsed or refractory diffuse large B-cell lymphoma, who were ineligible for autologous stem cell transplant, were randomly assigned to receive Pola-R-GemOx or R-GemOx.

Latest News

Diagnosis implicates high triglycerides as a contributor

A wave of recently approved therapies has improved options for the control of hidradenitis suppurativa, but surgery remains a possible option for faster clinical benefit.

Real-world data shows dupilumab had higher 1-year treatment continuation than oral or subcutaneous methotrexate and ciclosporin.

Rheumatologists and gastroenterologists don’t save their best drugs until last; neither should dermatologists.

An Expert TheraTalk on the Next Wave in Psoriasis Treatment: From Mechanistic Pathways to Clinical Practice

Updates in Hidradenitis Suppurativa: Underlying Pathogenic Mechanisms and Novel Targeted Treatments

News All Time

Novel Lupus Drugs Continue to Shine in Extended Early Data

For one of the two, the benefits continue long after treatment stops

Trump's Hair-Loss Drug; Bringing Americans With Ebola to U.S.; Widespread ACA Fraud?

Health news and commentary gathered by MedPage Today staff

Melanoma Vaccine Halves Risk of Recurrence, Metastasis Over 5 Years

Adjuvant approach will need confirmation from ongoing phase III trial, says expert

How Much Prednisone Is Too Much in Treating Rheum Effects From Cancer Therapies?

French study posits an answer

What Is Causing This Woman's Swollen Chin?

A long and challenging diagnostic path with twists and turns

FDA OKs First New Sunscreen Ingredient in a Quarter Century

Bemotrizinol blocks UVA and UVB and has been available in Europe since 1999

Is Microdosing Accutane Safe? Dermatologist Weighs In

Patients take the medication less frequently to reduce side effects while gleaning benefits

New Type of Maggots Cleared by FDA as Medical Treatment

Non-antibiotic approach can help deal with non-healing necrotic skin and soft tissue wounds

FDA Expands Risankizumab Label in Psoriatic Disease

IL-23 inhibitor lands indications for kids 6 years and up

CAR T-Cell Therapy for Skin Diseases Near Approval

CAR T-cell therapy is expected to expand quickly across autoimmune skin diseases following an anticipated regulatory approval that might come as soon as this year.

Eczema and the Topical Steroid Withdrawal Controversy

Topical steroid withdrawal is a controversial topic. What matters is treating patients with compassion and supporting them in their decision to stop treatment.

MCC Linked to Higher Mortality, Healthcare Use

Patients with Merkel cell carcinoma had higher mortality, more hospitalizations, and a greater comorbidity burden than matched patients without the disease and several other cancer cohorts in a study.

Judge Blocks Colorado's First-of-its-kind Price Cap on Amgen's Enbrel

A federal judge on Wednesday blocked Colorado from capping the price of Amgen's blockbuster arthritis drug Enbrel, a first-of-its-kind move ⁠by a U.S. state.

Androgenetic Alopecia Often Missed in Teens

Androgenetic alopecia is the most common form of hair loss in adolescents but often goes unrecognized even as new treatments are emerging for other forms of alopecia.

Evolving Goals Generate New Approaches to Aging Skin Rx

Ultrasound guidance of filler injections is just one example of cosmetic dermatologists adjusting to deliver a more natural and satisfactory modification of aging skin.

Ivermectin, Benzoyl Peroxide Top Metronidazole for Rosacea

Topical ivermectin and encapsulated benzoyl peroxide improve inflammatory lesions and severity compared with metronidazole in studies of patients with moderate-to-severe rosacea.

Recommended News For You

Coffee and tea linked to lower head and neck cancer risk

Study identifies new approach to protect the brain during radiation therapy

Analysis of projected cancer rates in Canada by 2024.

Nuclear missile workers are contracting cancer: They blame the bases

AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns

Avoiding Neuropathy From Chemo; Predictive Value of Screening EKGs

'Significant Milestone' for Radionuclide Therapy in Refractory Meningioma

Recommended Articles For You

All You Need to Know About Mesna: The Ultimate Guide 

Cutting-Edge Cancer Care: The Precision Revolution in Surgical Oncology 

Transplant Oncology and Anti-Cancer Immunosuppressants: The Evolution of a Paradigm in Cancer Care 

Rasburicase-Linked Methemoglobinemia in HCC: Risks, Mechanisms, and Management 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Taking Charge of Your Cancer Journey.

2.

Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma

3.

Adipocytes in the bone marrow offer early indicators of the development of multiple myeloma from MGUS.

4.

Trump Issues Gag Order for CDC, FDA; Stalled Hearing for RFK Jr.; Sex After Cancer

5.

"We Caught It Early": Advantage or Disadvantage?

1.

How HLH is Revolutionizing Healthcare

2.

Unlocking the Unknown: A Comprehensive Guide to Stage 4 Vulvar Cancer

3.

The Importance of Understanding Your D-Dimer Levels: A Comprehensive Guide

4.

Personalized Cancer Vaccines: The Next Frontier in Precision Oncology

5.

Exploring the Unknown: Unveiling the Mysteries of GIST Tumors

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion

2.

Efficient Management of First line ALK-rearranged NSCLC - Part IV

3.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV

5.

Navigating the Complexities of Ph Negative ALL - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot